Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pulmatrix Inc (NASDAQ:PULM)

1.67
Delayed Data
As of Sep 27
 +0.12 / +7.74%
Today’s Change
1.37
Today|||52-Week Range
6.14
-60.24%
Year-to-Date
No recent news for Pulmatrix Inc.

Today’s Trading

Previous close1.55
Today’s open1.58
Day’s range1.56 - 1.67
Volume15,469
Average volume (3 months)101,559
Market cap$22.7M
Dividend yield--
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+76.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio0.2
Price/Sales28.29
Price/Book0.69

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.00+1.00%
OPXAOpexa Therapeutics I...-0.03-0.93%
MBVXMabVax Therapeutics ...+0.07+1.68%
PVCTProvectus Biopharmac...-0.00-3.07%
Data as of 09/27/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.2M
Annual profit (last year)-$26.2M
Net profit margin-2,178.77%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert W. Clarke
Chief Financial Officer, Treasurer &
Secretary
William E. Duke
Corporate headquarters
Lexington, Massachusetts

Forecasts

Search for Jobs